维普中文期刊产品整合服务
18篇 您的检索式:作者名="Reinkensmeier"
    题名 作者 年代 出处 被引量
1Inhibition ofrestenosis in femoropopliteal arteries: paclitaxel-coatedversus uncoated balloon: femoral paclitaxel randomizedpilot trial显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,13:1
2N-butyldeoxygalactonojirimy- tin: a more selective inhibitor of glyeosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo 显示文摘Andersson U Reinkensmeier G 2000Biochem Pharmaeo12000,59,7:1
3Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial显示文摘Michael Werk Soenke Langner Bianka Reinkensmeier Hans-Frank Boettcher Gunnar Tepe Ulrich Dietz Norbert Hosten Bernd Hamm Ulrich Speck Jens Ricke 2008Circulation2008,,:1
4Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial显示文摘Michael Werk Soenke Langner Bianka Reinkensmeier Hans-Frank Boettcher Gunnar Tepe Ulrich Dietz Norbert Hosten Bernd Hamm Ulrich Speck Jens Ricke 2008Circulation2008,,13:1
5Inhibition of resten- osis in femoropopliteal arteries: paclitaxel-coated versus uncoa- ted balloon: femoral paclitaxel randomized pilot trial显示文摘Werk M Langner S Reinkensmeier B et ol 2008Circula- tion2008,118,13:1
6Inhibition of resteno- sis in femoropopliteal arteries:paclitaxel-coated versus uncoated bal- loon : femoral paclitaxel randomized pilot trial显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,13:1
7Inhibition of res- tenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial 显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,:1
8Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial显示文摘Michael Werk Soenke Langner Bianka Reinkensmeier Hans-Frank Boettcher Gunnar Tepe Ulrich Dietz Norbert Hosten Bernd Hamm Ulrich Speck Jens Ricke 2008Circulation2008,,13:1
9Inhibition of glycogen breakdown by imino sugars in vitro and in vivo 显示文摘Andersson U Reinkensmeier G Butters T D 2004Biochem Pharmacol2004,67,4:1
10Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase显示文摘Simpson MA Cross H Proukakis C Priestman DA Neville DC Reinkensmeier G 2004Nat Genet2004,36,11:1
11Prevention of lysosomai storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin 显示文摘Platt FM Neises GR Reinkensmeier G 1997Science1997,276,:1
12Inhibition of restenosis in femoropopliteal arteries: Paclitaxel-coated versus uncoated balloon 显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,13:1
13Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial 显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,13,:1
14Inhibition of restenosis in femoropopliteal arteries:paclitaxel-coated versus uncoated balloon:femoral paclitaxel randomized pilot trial 显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,13:1
15Inhibition of restenosis in femoropopliteal arteries:paclitaxel- coated versus uncoated balloon:femoral paclitaxel randomized pilot trial显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,:1
16Inhibition of restenosis in femoropopliteal arteries:paclitaxel-coated versus uncoated balloon:femoral paclitaxel randomized pilot trial显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,13:1
17Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial 显示文摘Werk M Langner S Reinkensmeier B 2008Circulation2008,118,13:1
18The Integration of Vacuum Brazing into Heat Treatment - A Progressive Combined Process显示文摘The continuous constructive challenge to improve the functionality and efficiency of components always results in higher demands on production engineering, against the background of the generally increasing cost pressure. In many cases, you will just succeed in producing competitive and innovative products by combining and coupling of different procedures to an independent (hybrid) technology. The use of hybrid procedures for metal joining and heat treatment of metallic materials finds more and more industrial fields of application. Modern vacuum lines with integrated pressurized gas quenching are considered high-performance and flexible means of production for brazing and heat treatment tasks as well in the turbine industry as in the mould making and tool manufacturing industry. In doing so, the heat treatment is coupled with the brazing cycle in a combined process so that the brazing temperatures and soak times are adapted to the necessary temperatures and times for solution heat treatment and austeniting. This user-oriented article describes on the one hand examples of brazing of turbine components, but above all the practical experience from the plastics processing industry, where the requirement for a high-efficient cooling of injection moulding dies gains more and more importance. The combined procedure 'Vacuum Brazing and Hardening' offers plenty of possibilities to produce mould inserts with an efficient tempering system in an economic way.Ingo Reinkensmeier Henkjan Buursen 2004材料热处理学报2004,25,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费